Neural Regeneration Research ›› 2021, Vol. 16 ›› Issue (7): 1436-1437.doi: 10.4103/1673-5374.301012

Previous Articles     Next Articles

Neuritogenic function of microglia in maternal immune activation and autism spectrum disorders

Srinidhi Venkatesan Kalavai#, Seiko Ikezu*, #   

  1. Department of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA

  • Online:2021-07-15 Published:2021-01-07
  • Contact: Seiko Ikezu, MD,sikezu@bu.edu.
  • Supported by:
    The present work was funded in part by Nancy Lurie Marks Family Foundation (to SI), Robert E. Landreth and Dona Landreth Family Foundation (to SI) and NIH 5P30 AG013846-23 (to SI).

    We thank Tsuneya Ikezu and Hana Yeh for the thorough review. 

Abstract: Autism spectrum disorder and maternal immune activation: Environmental factors during pregnancy, such as infections, maternal stress or autoimmune disorders, are closely associated with the prevalence of neurodevelopmental disorders including autism spectrum disorder (ASD), bipolar disorder and schizophrenia. It has been shown that severe infections during pregnancy cause maternal immune activation (MIA) and significantly increase the risk of ASD in the offspring although the mechanisms are poorly understood. Many rodent MIA studies support this causal link by showing that offspring of dams administered with polyinosinic:polycytidylic acid (polyI:C), a viral mimetic Toll-like receptor 3 agonist, exhibit long-lasting ASD-like behavioral abnormalities such as increased repetitive behavior, impaired social interaction and communication. Interestingly, MIA alters inflammatory cytokine expressions persisting through development and adulthood in the brain of the offspring, suggesting that chronic neuroimmune dysfunction plays a role in mediating the deleterious effects of MIA on neurodevelopment (Garay et al., 2013).